Bayer is looking for a speedy remedy for stagnant aspirin sales.
The company whose name is synonymous with the pain reliever is introducing a reformulated aspirin Monday that works in half the time of its regular aspirin.
Bayer says its aspirin is now better-known for preventing heart attack and stroke than for its pain reliever roots. Bayer AG says it needed to revitalize the brand and target younger customers. Expanding the demographic of users is key to budging Bayer’s 14.6 percent market share.
